# Short versus long antibiotic treatment for pyelonephritis and complicated UTIs: a living systematic review and meta-analysis of RCTs 

![Alt text for the image](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/Data/PLfunny.jpg)
*Generated by DALL-E*


רשימת דברים שצריך לפתור:
שינוי שם בכתובת ובכותרת
טבלת תאריכי חיפוש לפי דאטהבייס - להכניס תחת שיטות
קיצור המילים של החלק של השיטות, ולהכניס מידע על תהליך אוטומציה
טבלת תוצאות חיפוש כן/לא
קיצור טבלת GRADE לפי Summary of findings table
להוסיף עוד גרפים מהמאמר - cure מיקרוביולוגי, AE כללי ועוד  



## Latest Update
- **Last Search Date**: December 2024
- **Ongoing trials**: [Trial List](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/Data/Ongoing_trials_registry2024.md)
  

## Publication DOI:
ROOM FOR PUBLICATION DOI


## Living Systematic Review Methods 
PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Clinicaltrials.gov, European Medicines Agency (EMA) trial registry, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are configured to send automated monthly search updates according to the defined search strings (under data folder). Potentially eligible trials are transferred to Rayyan monthly by one author by rotation (IZ, DK). Searches in trial registries and conference proceedings are performed once yearly (MP). Once yearly, in December, eligible trials are selected from all searches by two authors (IZ, DK) and added to the systematic review. We extract the data and update the table of included studies, the risk of bias assessment, meta-analyses, and summary of findings tables, as necessary once yearly. The updated results will be available on this site with the last search date. When updates are no longer possible (personnel time availability), an end date will appear on the website.


## Results 
- [Risk of Bias 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Risk_of_bias24.png) 
- [Outcomes 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Outcomes2024.md)
- [Clinical Success Forest Plot 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Cinical_success2024.png) 
- [Death Forest Plot 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Mortality2024.png) 
- [Certainty Assessment 2024](https://gdt.gradepro.org/presentations/#/p_l_a_ce434133-8051-5d54-8b9a-18ebaf9fed63_9889d7e3-beb6-47ad-b446-29092410e129_e3bef251-77d5-4ac4-9e6a-665c73fccbbb) 

## Supplementary Data
- [Study Characteristics Table]TBC
- [PRISMA Flow Diagram 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/PRISMA2024.png)
- [Clinical Success Males Forest Plot 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Clinical_success_males2024.png)
- [Clinical Success Bacteremia Forest Plot 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Bacteremia2024.png)
- [Adverse Events Diarrhea Forest Plot 2024](https://github.com/ItayZahavi/living-SR-UTI-Tx-duration/blob/results/Diarrhea22024.png)


## Corresponding author 
[Itay Zahavi](mailto:itai1994@gmail.com)


